Papers
1
Total Citations
22
H-Index
1
About
Dr. Mei‐Lin Wu is a leading clinical researcher whose work centers on surgical outcomes and infection control, with a particular focus on improving patient safety in abdominal surgery. Her most impactful contribution is the landmark 2023 study, "Identification of Risk Factors and Phenotypes of Surgical Site Infection in Patients After Abdominal Surgery," which has already garnered 22 citations. In this work, Dr. Wu provided a critical, contemporary analysis of surgical site infection (SSI) epidemiology in China, establishing current incidence rates and identifying key risk factors. More importantly, she pioneered a novel approach by characterizing distinct clinical phenotypes of SSI, moving beyond simple risk assessment to a more nuanced understanding of how infections manifest in different patient populations. This work offers surgeons actionable insights for targeted prevention and personalized postoperative care. By bridging the gap between epidemiological data and clinical practice, Dr. Wu’s research directly informs strategies to reduce morbidity and healthcare costs, making her a vital voice in the global effort to enhance surgical quality and patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1